Technical Analysis for QGEN - Qiagen N.V.

Grade Last Price % Change Price Change
grade C 37.14 1.12% 0.41
QGEN closed up 1.12 percent on Friday, February 14, 2020, on 39 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical QGEN trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


QIAGEN N.V., through its subsidiaries, provides sample and assay technologies worldwide. It offers approximately 500 core consumable products, such as sample and assay kits, and automated instrumentation systems that empower customers to transform raw biological samples into molecular information. The company's consumable products are used for plasmid deoxyribonucleic acid (DNA) purification, and ribonucleic acid purification and stabilization; genomic and viral nucleic acid purification; nucleic acid transfection; polymerase chain reaction (PCR) amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. The company sells the digene HC2 HPV Test, a signal-amplified test for high-risk strains of the human papillomavirus. It also offers co-development services for companion diagnostics, technology licensing and patent sales services, and custom services, including whole genome amplification, DNA sequencing, and non-cGMP DNA production on a contract basis. The company's instrumentation systems automate the use of sample and assay technologies into solutions for a range of laboratory needs enabling customers to perform nucleic acid sample preparation, assay setup, target detection, and other laboratory tasks. Its automated systems include QIAsymphony, a modular system; Rotor-Gene Q, a rotary real-time PCR cycler system; PyroMark, a high-resolution detection platform based upon the Pyrosequencing technology; QIAcube, a sample processing instrument; QIAxcel for nucleic acid separation in low- to high-throughput laboratories; and ESE-Quant Tube Scanners, an optical measurement device. The company serves customer classes, including molecular diagnostics laboratories; applied testing customers in fields, such as forensics, veterinary diagnostics, and food safety; pharmaceutical research and development groups, and academic researchers. QIAGEN N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands.
Chemistry Biotechnology Biology Nature Molecular Biology Consumable Products Molecular Diagnostics Food Safety Laboratory Techniques Polymerase Chain Reaction Dna Sequencing HPV Instrumentation Systems Pharmaceutical Research Qiagen Cloning Real Time Polymerase Chain Reaction Technology Licensing

Is QGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 43.16
52 Week Low 25.04
Average Volume 2,672,133
200-Day Moving Average 36.14
50-Day Moving Average 36.67
20-Day Moving Average 35.08
10-Day Moving Average 35.45
Average True Range 0.86
ADX 22.18
+DI 33.42
-DI 21.88
Chandelier Exit (Long, 3 ATRs ) 34.63
Chandelier Exit (Short, 3 ATRs ) 35.56
Upper Bollinger Band 37.13
Lower Bollinger Band 33.03
Percent B (%b) 1.0
BandWidth 11.70
MACD Line 0.18
MACD Signal Line -0.23
MACD Histogram 0.4106
Fundamentals Value
Market Cap 8.48 Billion
Num Shares 228 Million
EPS 0.33
Price-to-Earnings (P/E) Ratio 112.55
Price-to-Sales 5.65
Price-to-Book 3.07
PEG Ratio 2.07
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.55
Resistance 3 (R3) 37.53 37.37 37.48
Resistance 2 (R2) 37.37 37.27 37.38 37.45
Resistance 1 (R1) 37.26 37.21 37.32 37.28 37.43
Pivot Point 37.10 37.10 37.13 37.11 37.10
Support 1 (S1) 36.99 37.00 37.05 37.01 36.85
Support 2 (S2) 36.83 36.94 36.84 36.83
Support 3 (S3) 36.72 36.83 36.80
Support 4 (S4) 36.74